MoneyWorks4Me

Bharat Immunological & Biologicals Corporation informs about cash flow statement

02 Dec 2019 Evaluate

In pursuance to the email received from the exchange dated 06.11.2019, Bharat Immunological & Biologicals Corporation has informed that the Cash Flow statement for the half year ended on 30.09.2019 is submitted.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1753.95
Dr. Reddys Labs. 1239.00
Cipla 1329.90
Lupin 1928.00
Zydus Lifesciences 1135.00
View more..